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Aim. Description the folate-related processes in the human placenta using the stoichiometric model and investi-
gation the system’s behavior under various conditions.Methods. The model is based on the stoichiometry of the
reactions of the folate-related processes at steady state conditions and constructed using CellNetAnalyzer. Beha-
vior of the system is described by elementary flux modes and control-effective fluxes depending on the activity of
methylenetetrahydrofolate reductase and methionine synthase and input methionine flux. Results. Change in me-
thylenetetrahydrofolate reductase activity causes a decrease in fluxes through the main routes of homocysteine
elimination and increases the need for 5-methyltetrahydrofolate. Methionine synthase inactivation reduces 5-me-
thyltetrahydrofolate consumption and increases the flux through the taurine syn-thesis. Lack of methionine leads
to increased 5-methyltetrahydrofolate consumption, reduced homocysteine concentration and reduces the fluxes
through the methionine cycle.Conclusions. Analysis of model functioning has shown the compliance of system’s
functioning changes with the clinic parameters. There is evidence that the homocysteine level as a marker of fo-
late-related processes functioning of is not sufficient to justify the therapy.
Keywords: folate-related processes, stoichiometric model, elementary flux mode, control-effective fluxes.
Introduction. The problem of pregnancy failure is the
issue of utmost significance. For instance, according to
some data the frequency of complications in Ukraine is
up to 60 % or even 90 % [1]. The threatened miscarria-
ge is a complication of about 40 % of pregnancies, the
early termination of pregnancy is remarkable for 20–25
%, and the preeclampsia is present in 10 % of pregnancies
[2]. The pathogenesis of a number of obstetric complica-
tions is yet to be defined in details, and the contribution of
a genetic component into their development is insuffici-
ently described in many cases. At present, barrenness and
miscarriage are considered to be the results of a common
action of the genetic and environment factors [3].
The research, described in this article, was based on
two propositions. According to the first one a vital role
in the pathogenesis of diseases is attributed to the pla-
cental metabolism [4], as the placenta is not only trans-
porting nutrients and metabolism products from the fe-
tus to the mother, but is also actively metabolizing them.
The placenta is a final barrier between the mother and
the fetus, and placental metabolism disorder is the main
factor of many pregnancy failures. According to the se-
cond proposition a vital role in the functioning of the
placenta cells and the developing cells is attributed to the
folate-dependent processes (FDP) [3]. Therefore, wo-
men are recommended to use the folic acid prior to the
conception and especially in the first three months of
pregnancy in order to prevent any pregnancy complica-
tions, in particular, the fetal neural tube defects.
The large-scale experimental research on the inter-
relations between the structure, function and regulation
in large metabolic networks is still a complicated and
costconsuming endeavor. The systems biology is solving
this issue, combining the results of different experimen-
tal approaches and bioinformatics methods, in particu-
lar, modeling. One of these approaches is a structure-
oriented analysis, which requires the knowledge of net-
work topology and the stoichiometry of biochemical re-
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actions, commonly known from the classic chemistry.
They are used to build a stoichiometry model, descri-
bing the distribution of stationary metabolic fluxes (the
metabolic flux is the rate of transformation of metabo-
lites) in the metabolic pathway (the metabolic pathway
is the sequence of chemical transformations of a certain
substance) in different conditions, but it does not take
into consideration the regulation, implemented in it.
The term «folate-dependent processes» is used to
determine a group of biochemical reactions, in which
the derivatives of folic acid, folates, are cofactors. The
center of FDP is formed by two related cycles – folate
and methionine cycles [5, 6]. FDPs in liver have been
studied the most extensively [7]. The folate cycle is re-
presented by the derivatives of the folic acid with diffe-
rent degrees of oxidation. The main functions of folates
are the transfer of one-carbon units in the biosynthesis
reactions of nucleobases and the metabolism of amino
acids as well as the transfer of a methyl group into the
methionine cycle. All the methylation processes in the
cell are related to the transformation of components in
the methionine cycle, in particular, these are DNA me-
thylation, the synthesis of amino acids – methionine and
cysteine, and indirectly – the synthesis of glutathione
and taurine. The most active FDPs are in the cytosol,
less active ones – in mitochondria and nucleus [8].
A special role in the FDP system is attributed to the
enzymes 5,10-methylenetetrahydrofolate reductase
(MTHFR, EC 1.5.1.20), methionine synthase (MS, EC
2.1.1.13), as well as the introduction of methionine (Met)
into the system. MTHFR – is a NADP-dependent enzy-
me, catalyzing the transformation of 5,10-methylene-
tetrahydrofolate (5,10-CH2-THF) into 5-methyltetra-
hydrofolate (5MTHF). The latter is a donor of the me-
thyl group in the reaction of homocysteine (Hcy) methy-
lation, resulting in the formation of Met with MS invol-
ved. It is known that the decrease in the enzymatic acti-
vity of the abovementioned enzymes due to mutations
or the deficiency of group B vitamins, which are cofac-
tors, as well as considerable fluctuations in the Met in-
put lead to the significant disorders in the fetal develop-
ment at the early stages of embryogenesis and even to
the fetal death [9].
Taking the aforesaid into consideration, this work
was aimed at the elaboration of a stoichiometry model
of the FDP in human placenta, the simulation of the de-
crease in the activity of the enzymes MTHFR, MS and
the Met input and the analysis of the behavior of the sys-
tem in these conditions.
Materials and methods. The mathematical descrip-
tion and the analysis of metabolic fluxes involved the
Flux Balance Analysis (FBA) which is based on the as-
sumption of the balance of metabolites and the linear
programming.
The elaboration of the stoichiometry model and the
conducted calculations included the following stages:
The mathematical description of folate-dependent
processes. The mat hematical model of the process, com-
posed of n reactions, is a system of differential equations
dS
dt
n describing the dynamics of the metabolite concent-
ration (S). FBA is used for systems in a steady state,
when
dS
dt
n
 0.
Therefore, the system of differential equations trans-
forms into the system of algebraic equations, which
may be presented in the form of a matrix [10].
The elaboration of a stoichiometry matrix based on
the system of algebraic equations. The stoichiometry
matrix is the matrixm q, where each element nij is a stoi-
chiometric coefficient, related to the metabolite i in the
reaction j with the corresponding sign: a negative sign
for the metabolite consumption, a positive sign – for its
formation; q – reactions (matrix columns);m – metabo-
lites (matrix rows) [11]. The matrix was created in Cell
NetAnalyser software 6.2.
The calculation of elementarymodes (elementary flux
modes, EFM) based on the stoichiometry matrix. EFM
is a directed pathway, including the minimal and unique
set of steady-state reactions [10]. The removal of any en-
zyme or any reaction from EFM leads to the termina-
tion of mode functioning. In mathematical terms, the
set of EFM is a set of independent basic vectors, corres-
ponding to the following conditions: a stoichiometry
matrix = 0, i. e. the vector is determined in a steady sta-
te; there is no other non zero vector to correspond to the-
se restrictions and to involve the same set of reactions
[11]. The number of EFM was calculated using CellNet
Analyzer 6.2 software. The defined frequency of the
participation of each reaction in different EFM testifies
to the significance of the reaction and it’s enzyme in the
functioning of the system.
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The calculation of control-effective fluxes. The signi-
ficance of each reaction for the efficient and flexible work
of the whole metabolic system was determined using the
control-effective fluxes (CEF) via this reaction in diffe-
rent EFM [12]. The analysis started with the assignment
of the efficiency value to each EFM (j, CELLOBJ).
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action in a certain EFM; j – EFM index; i – the index of
a flux via a specific reaction in a given EFM [13].
Then CEF (i) was defined for a certain reaction
(rj
i) as an average flux via this reaction in all EFM,
where the flux in each mode is balanced relative to its
efficiency [13].
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max is the maximal participation coefficient
in EFM for reactions, involved in the objective func-
tions of the cell;
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,
is the sum of the
products of participation coefficients for a certain
reaction for all EFM and the corresponding calculated
values of efficiency;
j j CELLOBJ

,
is the total value of
efficiency of all the modes.
To determine the behavior of the whole metabolic
system in the conditions of deficiency of any enzyme,
the participation coefficients for reactions in EFM, in-
volving a deficiency enzyme, were multiplied by the
constant dj, which reflects the degree of the enzyme in-
activation and takes the value from 1 to 0. The efficien-
cy values of these modes were also multiplied by dj.
The code for calculations was written in WolframMa-
tematica software 7.0. The example of calculations is
presented in Addendum 1.
Results and discussion. The first attempts to create
a stoichiometry model of the FDP metabolic network
for placenta on the basis of general data and the specifi-
cities of the relative genes expression in human placen-
ta [14] were made in the work [15]. In this work the sche-
me of the metabolic network was extended, in particu-
lar, we added the reactions of transformation of the glu-
tamic acid as well as the reactions of input and output of
metabolites [16] (Fig. 1).
The stoichiometry model is composed of 42 reac-
tions, including the following: 4 reactions of the methio-
nine cycle, 9 reactions of the tetrahydrofolate cycle, 2
transsulfuration reactions, 2 reactions of the glutathione
synthesis, 3 reactions of the taurine synthesis, 2 reactions
of the glutamic acid transformation and 20 reactions of
the input and output of metabolites (Addendum 2).
Elementary flux modes. Fifty-three EFMs were
calculated and isolated for FDP model in the cytosol of
placental cells (Addendum 3). All the modes are irre-
versible. Most EFMs involve the participation of the
following: the input flux Ser (37 EFM), the enzyme
SHMT (33 EFM), the output flux GSH (29 EFM), the
reaction of glutathione synthesis (28 EFM). Serine is
used in the SHMT and CBS reactions for the synthesis
of folates and Hcy transsulfuration. Glutathione is im-
portant to maintain the redox status of cells and to deto-
xify xenobiotics [17].
Other modes are responsible for the production of
taurine, aminoacids (Met, Gly, Ser, Hcy), dTMP, 5MT
HF and the methylation processes. There are also seven
modes, wherein the metabolites are not synthesized.
These are futile cycles, which occur when two metabo-
lic pathways run simultaneously in opposite directions,
use each other’s products and, as a result, do not have
other products, other than energy dissipation in the form
of heat and transport of some metabolites through the
placenta.
The EFM analysis demonstrates that there are no
indispensable enzymes in the created metabolic net-
work, i. e. the ones to take part in all the EFMs. This is
the evidence to the network flexibility.
CEF for the initial state. Seven most frequent reac-
tions in all the EFMs and thus the most significant re-
actions for the functioning of the system were selected
as the objective functions: Ser_in, SHMT, GSH_out,
CBS, MTHFR, DNMT, TS (Addendum 4).
The highest value of the control-effective flux is for
the serine input flux Ser_in, which is used in the synthe-
sis of cystathionine and is a donor of CH2 group in the
5,10-CH2-THF synthesis reactions. The lowest values of
CEF were obtained for reactions, related to the synthe-
sis and output of taurine (CDO, SADC, HTD, Taur_out)
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as well as the fluxes of input/output of some metaboli-
tes: Hcy_out, Fol_in, Taur_in, Gln_out (Addendum 5).
CEF in the simulation conditions. The mutations of
the MTHFR gene have been studied the most extensi-
vely. Almost 50 % of the Caucasian population in Eu-
rope have the polymorphism of MTHFR gene in posi-
tion 677 [18]. The homozygotes of T677T retain only
30 % of the activity, whereas the heterozygotes retain
65 % relative to the wild type [19]. MTHFR is the only
enzyme, capable of synthesizing 5MTHF, which is the
donor of the methyl group for the methionine cycle, the-
refore even its partial inactivation has a considerable
effect on the work of the whole network. The decrease
in the activity of MTHFR affects not only 5MTHF syn-
thesis and Hcy remethylation, but also the glutathione
synthesis and methylation processes. Fig. 2 presents
the dependence of CEF change on the inactivation de-
gree for this enzyme.
In Fig. 2 it is evident that the 0.5 inactivation degree
of the enzyme is a «breaking point, prior to which the
network is still attempting to «cope with» the increased
number of Hcy, gradually increasing the fluxes via the
reactions of its elimination – the reactions of synthesis
and removal of Cys and Taur, and the fluxes of 5MTHF
input for the Hcy remethylation processes. The reduc-
tion of fluxes via the reactions of the methionine cycle
is gradual. In case of the MTHFR inactivation over 0.5,
the Hcy output flux, the 5MTHF input flux, the synthe-
sis reaction fluxes (CDO, SADC, HTD), and the remo-
val of Cys and Taur reach the plateau. Therewith the
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Fig. 1. The metabolic network of the folate-dependent processes in placenta. Enzymes: AICAR – 5-aminoimidazole-4-carboxamide-ribotide;
AICART – phosphoribosyl aminoimidazole carboxamide formyltransferase; CBS – cystathionine beta-synthase; CDO – cysteine dioxygenase;
CTGL – cystathionine-gamma-lyase; DHFR – dihydrofolate reductase; DNMT – DNA-methyltransferase; FTS – formyltetrahydrofolate
synthetase; GCL – glutamate cysteine ligase; GLS – glutaminase; GLUD – glutamate dehydrogenase; GNMT – glycine-N-methyltransferase; GS –
glutathione synthetase; HTD – hypotaurine dehydrogenase; MAT – methionine adenosyltransferase; MS – methionine synthetase; MTCH –
methenyltetrahydrofolate cyclohydrolase; MTD – methylenetetrahydrofolate dehydrogenase; MTHFR – methylenetetrahydrofolate reductase;
PGT – phosphoribosyl formyltransferase; SADC – cysteine sulfamoyl acid decarboxylase; SAHH – S-adenosyltransferase; SHMT – serine me-
thyltransferase; TS – thymidine synthase. Metabolites: 10-f-THF – 10-formyltetrahydrofolate; 5,10-CH=THF – 5,10- methenyltetrahydrofolate;
5,10-CH
2
-THF – 5,10-methylenetetrahydrofolate; 5MTHF – 5-methyltetrahydrofolate; Cys – cysteine; Cyst – cystathionine; DHF – dihydrofola-
te; dTMP – deoxythymidine monophosphate; dUmp – deoxyadenosine monophosphate; GAR – glycinamide ribonucleotide; Glu – glutamic acid;
GlutCys – glutamyl cysteine; Gly – glycine; GSH – glutathione; Hcy – homocysteine; SAM – S-adenosylmethionine; SAH – S-adenosylhomocys-
teine; Ser – serine; THF – tetrahydrofolate; Met – methionine
fluxes via the reactions of the methionine cycle and Met
input are reduced as well.
For instance, 30 % activity of MTHFR (677TT ge-
notype, 0.7 inactivation degree) leads to the reduction
of the flux via the reactions of the methionine cycle by
20 %, via MS – by 40 %, the reduction of the Met input
flux by 7 % with the increase in the flux of output Hcy
and input 5MTHF by 100 % and the output fluxes of Cys
and Taur – by 14 %. This correlation of fluxes in the
placental tissue facilitates the Hcy accumulation. The
change in MTHFR activity does not reflect on the CEF
of folate cycle fluxes – FTS, MTCH, MTD, DHFR.
The results of calculations are in agreement with
the scientific literature data. In the clinical practice the
carriage of MTHFR mutant forms in human placenta
prevails in case of a complicated pregnancy and is rela-
ted to the reduction in Hcy remethylation in favor of the
synthesis of nucleotides [20–22]. The simulation results
demonstrate that the presence of MTHFR mutant forms
leads to a considerable reduction in the flux via the re-
action, catalyzed by MS, due to the reduction in 5MTHF
production. The decreased intake of the folic acid and
group B vitamins (coenzymes for MS and CBS) with
food may lead to the failure of the compensation proces-
ses and the development of homocysteinemia.
Therefore, it was the first simulated behavior of all
the FDP reactions in conditions of reduced MTHFR ac-
tivity which promoted a better understanding of the lo-
gics of the system functioning. The MS-catalyzed reac-
tions as well as the Hcy output and the 5MTHFR input
demonstrated the highest sensitivity to the change in the
MTHFR activity. The reduction of the flux via the Hcy
remethylation reaction and the disproportional increase
in the transsulfuration promote the Hcy accumulation
in the system.
Another vital enzyme in the FDP network is the vita-
min B12-dependent MS. There are over 13 mutations of
the MS gene [23], which, depending on their localiza-
tion, may lead to the decrease in the enzyme activity.
Three metabolic pathways cross in MS: the exchange
of folates, vitamin B12 and sulfur-containing amino-
acids. Therefore the decreased activity of this enzyme
will result in the decreased or completely absent syn-
thesis of methylcobalamin (one of the vitamin B12 forms),
hyperhomocysteinemia and hypomethioninemia [24].
Fig. 3 presents the dependence of CEF change on
the inactivation degree of the enzyme. According to the
obtained data, the MS deficiency leads to a sharp decli-
ne in the 5MTHF flux, coming from outside. There is
also a sharp reduction in the 5MTHF production in the
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Fig. 2. The change of control-effective fluxes (CEF) depending on the
inactivation degree of MTHFR enzyme: 1 – Hcy input flux, 5MTHF
output flux; 2 – Taur, Cys output flux, CDO, SADC, HTD; 3 – Met in-
put flux; 4 – the methionine cycle reactions; 5 – MS; 6 – THF input flux
and Met, 5MTHF output flux. Y-axis contains CEF, scaled to the same
index with a completely functional enzyme; X-axis reads as follows: 0 –
a completely functional enzyme; 1 – complete inactivation of the en-
zyme. The change of CEF was introduced in the figure for the most
relevant reactions
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Fig. 3. The change of control-effective fluxes (CEF) depending on the
inactivation degree of MS enzyme: 1 – Hcy input flux; 2 – Taur, Cys
output flux, Taur synthesis reactions; 3 – Met input flux; 4 – the trans-
sulfuration reactions; 5 – the methionine cycle reactions; 6 – MTHFR;
7 – 5MTHF input flux. Y-axis contains CEF, scaled to the same index
with a completely functional enzyme; X-axis reads as follows: 0 – a
completely functional enzyme; 1 – complete inactivation of the enzy-
me. The change of CEF was introduced in the figure for the most
relevant reactions
MTHFR-catalyzed reaction. The flux via the methioni-
ne cycle decreases. The flux via the reactions of trans-
sulfuration and the taurine synthesis increases by 15 %.
There is a significant, up to two-fold increase in the flux
of output Hcy.
Therefore, the increase in the output Hcy flux and
an insufficient increase in the fluxes via the main ways
of its utilization will result in its accumulation in the
system.
In this case the increased consumption of folates will
not result in the normalization of the Hcy level in the
plasma, as MS is the only enzyme, capable of metaboli-
zing 5MTHF. The relevance of the normal work of the
methionine cycle, MS in particular, for the fetal deve-
lopment is proven by the data of Swanson et al., accor-
ding to which the homozygous MS-deficient mice had
high embryonic mortality, regardless of the high content
of folates in the diet, whereas the heterozygotes had the
increased Hcy level [25].
As for humans, the defects in MS gene lead to me-
thylcobalamin deficiency G (cblG) [MIM:250940], al-
so known as homocystinuriamegaloblastic anemia, G
complementation type [26]. Less apparent MS activity
deficiency may be associated with moderate hyperho-
mocysteinemia, be a risk factor for the fetal neural tube
defects [27] and other pathologies of the cardiovascular
and nervous systems.
Due to the relevance of the MS enzyme for the Hcy
utilization, it is reasonable to prescribe vitamin B12 to
pregnant women as it is the cofactor for MS [28].
The diets with poor Met level also affect the redistri-
bution of fluxes in the FDP system (Fig. 4). There is a
sharply growing need of 5MTHF, but the flux via the
MS reaction is increasing insignificantly (up to 5%)
and the activity of the methionine cycle processes is
decreased not much (< 10 %). The Hcy level remains
stable for still some time. The increase in the Met defi-
ciency (less than a half of the initial state) leads to the
decrease in the fluxes via the methionine cycle reac-
tions, the transsulfuration reactions and the output Hcy
flux is also greatly decreased.
The low Met concentration in the plasma will pro-
mote the prevalent Hcy remethylation [29]. The trials in-
volving volunteers demonstrated contradicting results:
both increased Hcy concentration in people who fol-
lowed a vegetarian diet or a diet with decreased Met
consumption [30, 31] and the absence of this dependen-
ce [29]. The vegetarians had the increased content of
folates in the plasma along with the low content of
vitamin B12, which may lead to MS deficiency and the
increase in the Hcy concentration [30].
Conclusions. The elaborated stoichiometry model
of FDPs in human placenta has been applied for the
analysis of the system behavior in conditions of the de-
creased activity of MTHFR and MS as well as the input
of Met into the system. The model utilizes the literature
data and may be used to investigate the FDP network
functioning and to predict its behavior in previously un-
studied situations.
It has been demonstrated that the decrease in the
MTHFR activity triggers the imbalance in the FDP net-
work in human placenta, increases the 5MTHF consum-
ption and promotes the Hcy accumulation. The results
demonstrate that the reduction of fluxes via the main
pathways of Hcy elimination (MS, the methionine cyc-
le reactions, the reactions of cysteine and taurine syn-
thesis) leads to its accumulation in the system. In addi-
tion, we have shown the effect of the decreased MTHFR
activity on the processes of transsulfuration and Taur
synthesis as well as the connection between MTHFR
and MS – the decrease in the activity of one of them
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Fig. 4. The change of control-effective fluxes (CEF) depending on the
Met input into the system: 1 – 5MTHF input flux; 2 – MS; 3 – the trans-
sulfuration reactions; 4 – the methionine cycle reactions; 5 – Hcy out-
put flux. Y-axis contains CEF, scaled to the same index in the norm;
X-axis reads as follows: 1 – normal input; 0 – the metabolite is not trans-
ported. The change of CEF was introduced in the figure for the most
relevant reactions
leads to the reduction of flux via the other, the deficien-
cy of both promotes the accumulation of homocysteine.
The MS inactivation also has a considerable effect
on the redistribution of fluxes in the network, especi-
ally on the pool of the folic acid, thus decreasing the
5MTHF consumption by the network and promoting
the Hcy accumulation. Likewise the decrease in the MS
activity affects directly related processes and also in-
creases the synthesis and removal of Taur – an amino
acid, required for the fetal development.
The insufficient consumption of Met leads to the in-
crease in the 5MTHF consumption, the decrease in the
Hcy content and the reduction of fluxes via the methio-
nine cycle. The simulation results demonstrate relevant
consequences of the Met consumption, which is half as
large as the initial one.
The stoichiometry model has proven to be a conve-
nient instrument in the research on how the change of
different parts of the system affects the whole system.
The simulation allows tracing the change of all the sys-
tem components and their interrelations as well as esti-
mating the change of which fluxes leads to the final re-
sults (the increase in the content of Hcy, Cys, Taur, the
decrease in the content of folates), which are observed
in the clinical practice. This fact testifies to the possibili-
ty of using this model to predict changes in the FDP
system with different rates of the system com-ponents.
The consideration of the content of folates, methionine
and group B vitamins as a prerequisite of the functional
activity of enzymes, and not merely the Hcy level as the
main marker of FDP functioning, is required for the pur-
poses of prescribing any well-grounded therapy.
Ìàòeìàòè÷íå ìîäåëþâàííÿ ôîëàò-çàëåæíèõ ïðîöåñ³â
ó ïëàöåíò³ ëþäèíè
Â. À. Äîöåíêî, Ì. Þ. Îáîëåíñüêà
Ðåçþìå
Ìåòà. Îïèñàòè ôîëàò-çàëåæí³ ïðîöåñè â ïëàöåíò³ ëþäèíè çà äî-
ïîìîãîþ ñòåõ³îìåòðè÷íî¿ ìîäåë³ ³ äîñë³äèòè ïîâåä³íêó ñèñòåìè
çà ð³çíèõ óìîâ.Ìåòîäè. Ìîäåëü ñòâîðåíî íà îñíîâ³ ñòåõ³îìåòð³¿
ðåàêö³é ôîëàò-çàëåæíèõ ïðîöåñ³â, ùî ïåðåáóâàþòü ó ñòàö³îíàð-
íîìó ñòàí³, ç âèêîðèñòàííÿì ïðîãðàìè CellNetAnalyzer. Ïîâåä³í-
êó ñèñòåìè îõàðàêòåðèçîâàíî ÷åðåç åëåìåíòàðí³ ìîäè ³ êîåô³ö³ºí-
òè êîíòðîëþ çà ïîòîêàìè çàëåæíî â³ä àêòèâíîñò³ ìåòèëåíòåò-
ðàã³äðîôîëàò-ðåäóêòàçè ³ ìåò³îí³íñèíòàçè ³ íàäõîäæåííÿ ìå-
ò³îí³íó. Ðåçóëüòàòè. Çì³íà àêòèâíîñò³ ìåòèëåíòåòðàã³äðîôî-
ëàò-ðåäóêòàçè ñïðè÷èíÿº çíèæåííÿ ïîòîê³â ÷åðåç îñíîâí³ øëÿõè
åë³ì³íàö³¿ ãîìîöèñòå¿íó òà çá³ëüøåííÿ ïîòðåáè ó 5-ìåòèëòåòðà-
ã³äðîôîëàò³. ²íàêòèâàö³ÿ ìåò³îí³íñèíòàçè çìåíøóº ñïîæèâàííÿ
5-ìåòèëòåòðàã³äðîôîëàòó ³ çá³ëüøóº ïîòîêè ÷åðåç ðåàêö³¿ ñèí-
òåçó òàóðèíó. Áðàê ìåò³îí³íó ïðèçâîäèòü äî çðîñòàííÿ ñïîæè-
âàííÿ 5-ìåòèëòåòðàã³äðîôîëàòó, çìåíøåííÿ âì³ñòó ãîìîöèñòå¿-
íó òà çíèæåííÿ ïîòîê³â ÷åðåç ðåàêö³¿ ìåò³îí³íîâîãî öèêëó. Âèñ-
íîâêè. Àíàë³ç ôóíêö³îíóâàííÿ ìîäåë³ âèÿâèâ â³äïîâ³äí³ñòü çì³í ó
ôóíêö³îíóâàíí³ ñèñòåìè êë³í³÷íèì ïîêàçíèêàì. Àëå º ñâ³äîöòâà
òîãî, ùî ð³âåíü ãîìîöèñòå¿íó ÿê ìàðêåðà ôóíêö³îíóâàííÿ ôîëàò-
çàëåæíèõ ïðîöåñ³â º íåäîñòàòí³ì äëÿ ïðèçíà÷åííÿ îáãðóíòîâà-
íî¿ òåðàï³¿.
Êëþ÷îâ³ ñëîâà: ôîëàò-çàëåæí³ ïðîöåñè, ñòåõ³îìåòðè÷íà ìî-
äåëü, åëåìåíòàðíà ìîäà, êîåô³ö³ºíòè êîíòðîëþ çà ïîòîêàìè.
Ìàòeìàòè÷åñêîå ìîäåëèðîâàíèå ôîëàò-çàâèñèìûõ ïðîöåññîâ
â ïëàöåíòå ÷åëîâåêà
Â. À. Äîöåíêî, Ì. Þ. Îáîëåíñêàÿ
Ðåçþìå
Öåëü. Îïèñàòü ôîëàò-çàâèñèìûå ïðîöåññû â ïëàöåíòå ÷åëîâåêà
ñ ïîìîùüþ ñòåõèîìåòðè÷åñêîé ìîäåëè è èññëåäîâàòü ïîâåäåíèå
ñèñòåìû â ðàçëè÷íûõ óñëîâèÿõ.Ìåòîäû. Ìîäåëü ñîçäàíà íà îñíî-
âå ñòåõèîìåòðèè ðåàêöèé ôîëàò-çàâèñèìûõ ïðîöåññîâ, íàõîäÿ-
ùèõñÿ â ñòàöèîíàðíîì ñîñòîÿíèè, ñ èñïîëüçîâàíèåì ïðîãðàììû
CellNetAnalyzer. Ïîâåäåíèå ñèñòåìû îõàðàêòåðèçîâàíî ñ ïðèìå-
íåíèåì ýëåìåíòàðíûõ ìîä è êîýôôèöèåíòîâ êîíòðîëÿ çà ïîòîêà-
ìè â çàâèñèìîñòè îò àêòèâíîñòè ìåòèëåíòåòðàãèäðîôî-ëàò-
ðåäóêòàçû è ìåòèîíèíñèíòàçû è ïîñòóïëåíèÿ ìåòèîíèíà. Ðå-
çóëüòàòû. Èçìåíåíèå àêòèâíîñòè ìåòèëåíòåòðàãèäðîôîëàò-ðå-
äóêòàçû âûçûâàåò ñíèæåíèå ïîòîêîâ ÷åðåç îñíîâíûå ïóòè ýëè-
ìèíàöèè ãîìîöèñòåèíà è óâåëè÷èâàåò ïîòðåáíîñòü â 5-ìåòèë-
òåòðàãèäðîôîëàòå. Èíàêòèâàöèÿ ìåòèîíèíñèíòàçû óìåíüøàåò
ïîòðåáëåíèå 5-ìåòèëòåòðàãèäðîôîëàòà è óâåëè÷èâàåò ïîòîêè
÷åðåç ðåàêöèè ñèíòåçà òàóðèíà. Íåäîñòàòîê ìåòèîíèíà ïðèâî-
äèò ê ðîñòó ïîòðåáëåíèÿ 5-ìåòèëòåòðàãèäðîôîëàòà, óìåíüøå-
íèþ ñîäåðæàíèÿ ãîìîöèñòåèíà è ñíèæåíèþ ïîòîêîâ ÷åðåç ðåàê-
öèè ìåòèîíèíîâîãî öèêëà. Âûâîäû. Àíàëèç ôóíêöèîíèðîâàíèÿ ìî-
äåëè âûÿâèë ñîîòâåòñòâèå èçìåíåíèé â ôóíêöèîíèðîâàíèè ñèñ-
òåìû êëèíè÷åñêèì ïîêàçàòåëÿì. Íî åñòü ñâèäåòåëüñòâà òîãî,
÷òî óðîâåíü ãîìîöèñòåèíà êàê ìàðêåðà ôóíêöèîíèðîâàíèÿ ôîëàò-
çàâèñèìûõ ïðîöåññîâ ÿâëÿåòñÿ íåäîñòàòî÷íûì äëÿ íàçíà÷åíèÿ
îáîñíîâàííîé òåðàïèè.
Êëþ÷åâûå ñëîâà: ôîëàò-çàâèñèìûå ïðîöåññû, ñòåõèîìåòðè-
÷åñêàÿ ìîäåëü, ýëåìåíòàðíàÿ ìîäà, êîýôôèöèåíò êîíòðîëÿ çà
ïîòîêàìè.
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